Magnesium sulphate and severe preeclampsia: Its use in current practice;Sulfate de magnésium et pré-éclampsie sévère: Innocuité en pratique courante dans des indications ciblées

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 34, Issue 1, 2005, Pages 17-22

  Girard, B ^a   Beucher, G ^a   Muris, C ^a   Simonet, T ^a   Dreyfus, M ^a  

^a CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

Magnesium sulphate; Preeclampsia; Pregnancy; Side effects

Indexed keywords

ACEBUTOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; LABETALOL; MAGNESIUM SULFATE;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; BOLUS INJECTION; DRUG INDICATION; DRUG OVERDOSE; FEMALE; HELLP SYNDROME; HUMAN; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; PREECLAMPSIA; PREGNANCY; PROTEINURIA; RETROSPECTIVE STUDY; SIDE EFFECT; TREATMENT OUTCOME;

EID: 13244273702     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0368-2315(05)82666-3     Document Type: Article

References (20)

1. WHO, UNICEF. Revised 1990 estimates of maternal mortality: WHO/FRH/MSM/96.11. Geneva: WHO, 1996.
2. Bouvier-Colle MH, Deneux C, Szego E, Couet C, Michel E, Varnoux N et al. Estimation de la mortalité maternelle en France: une nouvelle méthode. J Gynecol Obstet Biol Reprod 2004; 33: 421-9.
3. The Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the collaborative Eclampsia Trial. Lancet 1995; 345: 1455-63.
4. Do women with pre-eclampsia and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. The Magpie Trial Collaborative Group. Lancet 2002; 359: 1877-90.
5. Witlin AG, Sibai BM. Magnesium sulphate therapy in preeclampsia and eclampsia. Obstet Gynecol 1998; 92: 883-9.
6. Coetzee EJ, Dommisse J, Anthony JA. Randomised controlled trial of intravenous magnesium sulphate versus placebo in the management of women with pre- eclampsia. Br J Obstet Gynaecol 1998; 105: 300-3.
7. Belfort MA, Anthony J, Saade GR, Allen JC. A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. N Engl J Med 2003; 348: 304-11.
8. Livingston JC, Livingston LW, Ramsey R, Mabie BC, Sibai BM. Magnesium sulfate in women with mild preeclampsia: a randomized controlled trial. Obstet Gynecol 2003; 101: 217-20.
9. Idama TO, Lindow SW. Magnesium sulphate for preeclampsia: a review of clinical pharmacology applied to obstetrics. Br J Obstet Gynaecol 1998; 105: 260-8.
10. Ben-Ami M, Giladi Y, Shalev E. The combination of magnesium sulphate and nifedipine: a cause of neuromuscular blockade. Br J Obstet Gynaecol 1994; 101: 262-3.
11. Rasch DK, Huber PA, Richardson CJ, L'Hommedieu CS, Nelson TE, Reddi R. Neurobehavioral effects of neonatal hypermagnesemia. J Pediatr 1982; 100: 272-6.
12. Atkinson MW, Belfort MA, Saade GR, Moise KJJ. The relation between magnesium sulfate therapy and fetal heart rate variability. Obstet Gynecol 1994; 83: 967-70.
13. Mittendorf R, Covert R, Boman J, Khoshnood B, Lee K-S, Siegler M. Is tocolytic magnesium sulphate associated with increased total paediatric mortality? Lancet 1997; 350: 1517-8.
14. Mittendorf R, Dambrosia J, Pryde PG, Lee KS, Gianopoulos JC, Besinger RE et al. Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants. Am J Obstet Gynecol 2002; 186: 1111-8.
15. Grether JK, Hoogstrate J, Selvin S, Nelson KB. Magnesium sulfate tocolysis and risk of neonatal death. Am J Obstet Gynecol 1998; 178: 1-6.
16. Witlin AG, Saade GR, Mattar F, Sibai BM. Risk factors for abruptio placentae and eclampsia: analysis of 445 consecutively managed women with severe preeclampsia and eclampsia. Am J Obstet Gynecol 1999; 180: 1322-9.
17. Eclampsie. Pharmacologie clinique du sulfate de magnésium. In: Réanimation des formes graves de pré-éclampsie. Conférence d'experts de la Société Française d'Anesthésie et de Réanimation. Elsevier Ed, Paris, 2000, pp 107-128.
18. Douglas KA, Redman CW. Eclampsia in the United Kingdom. Br Med J 1994; 309: 1395-400.
19. Dayicioglu V, Sahinoglu Z, Kol E, Kucukbas M. The use of standard dose of magnesium sulfate in prophylaxis of eclamptic seizures: do BMI alterations have any effect on success? Hypert Pregn 2003; 22: 257-65.
20. Duley L. Magnesium sulphate regimens for women with eclampsia: messages from the Collaborative Eclampsia trial. Br J Obstet Gynaecol 1996; 103: 103-5.